European Union
Regulator: Not represented
not_approved
As of: 9/9/2026 · Temporal status not established
Regulatory context incomplete: regulator.
Scientific intelligence record
Experience 2.0
Growth hormone secretagogue peptide
Synthetic growth-hormone secretagogue and ghrelin-receptor agonist studied in endocrine challenge testing.
Record status
Traceability partial
Last meaningful update: 9/9/2026
Governed reviewed evidence
25
Governed records, not an efficacy score or total literature count.
Evidence boundary
0 / 25
Claim-linked support versus recorded evidence.
Research gaps
1
Unresolved questions remain visible.
Human experience
Below display gate
Observations never become clinical evidence.
Human experience · separate evidence stream
Eligible observations remain below the privacy and reliability threshold. WPF will not convert a handful of reports into a percentage, trend, or clinical claim.
Observation is valuable human context. It is not evidence of causation, efficacy, or safety.
Public display gate
n ≥ 20 eligible observations
Exact progress remains private before the threshold.
Intelligence snapshot
A compact view of what is represented, what remains unresolved, and how completely the record can be traced.
Governed reviewed evidence
25
Reviewed database records promoted through the governed publication workflow.
Contradictions
0
Conflicting evidence relationships that remain visible.
Research gaps
1
Questions the current record identifies as unresolved.
Connected media
0
Media records explicitly linked to this scientific record.
What we know
The project separates represented evidence from qualification, contradiction, uncertainty, and what the evidence does not establish.
This does not mean the scientific literature contains no findings. It means no reviewed institutional claim has been represented here.
Scientific context
Existing reviewed chemistry is preserved as scientific context. Chemistry and mechanism information do not establish clinical efficacy or safety.
Chemical identity describes the recorded molecular information. It does not establish biological activity, clinical efficacy, safety, or therapeutic suitability.
Explore further
Move from this peptide record into the project's broader evidence, research, comparison, and methodology systems.
Research
Chronology, unresolved research questions, opportunities, and researcher activity remain descriptive rather than evaluative.
1993 · study · Temporal status not established
The Journal of pediatric endocrinology
1996 · study · Temporal status not established
Clinical endocrinology
1997 · study · Temporal status not established
European journal of endocrinology
1998 · study · Temporal status not established
European journal of endocrinology
2000 · study · Temporal status not established
Connections
Connections appear only when they are represented by the project’s underlying records.
institution
institution
institution
institution
Traceability
The experience makes incomplete links visible instead of presenting a false impression of perfect provenance.
Source publication state
A governed source may be verified and approved for publication while its claim-to-evidence link is still incomplete.
Reviewer provenance state
“Human scientist reviewed: no” means that specific source-path attribution is not recorded. It does not silently negate the separate publication-review state.
Claim → Evidence
Incomplete
Evidence → Source
Connected
Source → Original record
Connected
Traceability documents how the project connects statements to records. It does not establish that a source is scientifically valid or that a claim is clinically true.
Incomplete links: claim-to-evidence
A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency.
Observational archive
Observational archive data is intentionally separated from published scientific evidence.
Observational boundary
Insufficient eligible observations are available for display under the current filters.
Insufficient eligible observations are currently represented to display aggregated findings for this peptide.
Regulatory context
Regulatory status is jurisdiction-specific and time-dependent. It is presented as context, not as a recommendation for use or a substitute for scientific evidence evaluation.
European Union
Regulator: Not represented
As of: 9/9/2026 · Temporal status not established
Regulatory context incomplete: regulator.
United States
Regulator: Not represented
As of: 9/9/2026 · Temporal status not established
Regulatory context incomplete: regulator.
Research + media
Only media explicitly linked through the project’s relationship system appears here.
No scientifically connected media is currently represented for this peptide.
Sources + provenance
GHRP-2 evidence · ranking key
A tier describes the evidentiary role and design strength of a source. It is not a popularity score, proof that every conclusion is correct, or a substitute for claim-level review.
Large, well-conducted randomized trials; prespecified major outcomes; rigorous systematic reviews or meta-analyses; and major regulatory assessments.
Smaller randomized trials, strong prospective cohorts, prespecified secondary analyses, and high-quality comparative-effectiveness studies.
Retrospective cohorts, claims-database studies, pharmacovigilance analyses, mechanistic human research, and well-documented case series.
Case reports, conference abstracts, preclinical research, hypothesis-generating analyses, and expert commentary.
Tier classifies source design and evidentiary role. Confidence reflects risk of bias, sample size, comparator quality, outcome relevance, follow-up, missing data, directness, replication, reporting quality, and whether conclusions stay within the measured results.
peptide explorer
Evidence-class labeling remains visible even when interactive rendering is unavailable. Representative geometry is not an experimentally determined or predicted biological conformation.
Fully specified molecular identity
Non-standard residues and stereochemistry are exact in notation, not inferred from the viewer.
Sources: NIH PubChem — Pralmorelin / GHRP-2 · reviewed 2026-09-17
Governed scientific evidence
Duplicate-safe scientific sources under accountable human review. Identified or pending records do not contribute as approved evidence.
Audit view
Human and preclinical evidence remain separate. Source identity, claim-to-source traceability, review dates, conflicts, limitations, and unknowns stay visible rather than being collapsed into one score.
PubMed-indexed controlled clinical trial; journal article; research support, non-u.s. gov't; validation study examining a simple diagnostic test using gh-releasing peptide-2 in adult gh deficiency. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed clinical trial; comparative study; journal article; randomized controlled trial; research support, non-u.s. gov't examining pituitary responsiveness to gh-releasing hormone, gh-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; review examining pralmorelin: ghrp 2, gpa 748, growth hormone-releasing peptide 2, kp-102 d, kp-102 ln, kp-102d, kp-102ln. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining pharmacological characteristics of kp-102 (ghrp-2), a potent growth hormone-releasing peptide. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed comparative study; journal article; research support, u.s. gov't, p.h.s. examining gh releasing peptides--structure and kinetics. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining glycine-modified growth hormone secretagogues identified in seized doping material. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining analysis of new growth promoting black market products. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining detection of black market follistatin 344. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, u.s. gov't, p.h.s. examining growth hormone releasing peptide-2 (ghrp-2), like ghrelin, increases food intake in healthy men. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't; review examining growth hormone-releasing peptides. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s. examining the hexapeptide kp-102 (d-ala-d-beta-nal-ala-trp-d-phe-lys-nh(2)) stimulates growth hormone release in a cichlid fish (ooreochromis mossambicus). Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining intraportal infusion of ghrelin could inhibit glucose-stimulated glp-1 secretion by enteric neural net in wistar rat. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining ipamorelin, the first selective growth hormone secretagogue. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining structure-activity relationship for peptídic growth hormone secretagogues. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining synthesis of mono-pegylated growth hormone releasing peptide-2 and investigation of its biological activity. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining determination of the immunostimulatory drug-glucosoaminyl-muramyl-dipeptide-in human plasma using hplc-ms/ms and its application to a pharmacokinetic study. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining general pharmacology of kp-102 (ghrp-2), a potent growth hormone-releasing peptide. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining metabolism of growth hormone releasing peptides. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining growth hormone secretagogue treatment in hypogonadal men raises serum insulin-like growth factor-1 levels. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining kp-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article; research support, non-u.s. gov't examining growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining acth releasing activity of kp-102 (ghrp-2) in rats is mediated mainly by release of crf. Machine-staged source candidate; findings and limitations require accountable review before publication.
PubMed-indexed journal article examining growth hormone releasing peptide-2 attenuation of protein kinase c-induced inflammation in human ovarian granulosa cells. Machine-staged source candidate; findings and limitations require accountable review before publication.
The Journal of endocrinology
2004 · study · Temporal status not established
Drugs in R&D
2004 · study · Temporal status not established
Arzneimittel-Forschung
2004 · study · Temporal status not established
Arzneimittel-Forschung
2005 · study · Temporal status not established
The Journal of clinical endocrinology and metabolism
2005 · study · Temporal status not established
Naunyn-Schmiedeberg's archives of pharmacology
2006 · study · Temporal status not established
Naunyn-Schmiedeberg's archives of pharmacology
2007 · study · Temporal status not established
European journal of endocrinology
2009 · study · Temporal status not established
Regulatory peptides
2012 · study · Temporal status not established
Analytical chemistry
2014 · study · Temporal status not established
BioMed research international
2015 · study · Temporal status not established
AAPS PharmSciTech
2016 · study · Temporal status not established
International journal of molecular sciences
2017 · study · Temporal status not established
Drug testing and analysis
2017 · study · Temporal status not established
American journal of men's health
2018 · study · Temporal status not established
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
2018 · study · Temporal status not established
Endocrine journal
2019 · study · Temporal status not established
Drug testing and analysis
2019 · study · Temporal status not established
Drug testing and analysis
2020 · study · Temporal status not established
Biomedical chromatography : BMC
2022 · study · Temporal status not established
PloS one
2026 · regulatory · Temporal status not established
European Union
2026 · regulatory · Temporal status not established
United States
The represented chronology reflects records currently included in the governed dataset and does not claim to represent the entire scientific literature.
No institutional claim record is currently represented for this peptide.
Evidence is missing or not represented as studied; this is not a conclusion that the intervention does not work.
These are bibliographic author identities derived from represented records. Name strings are not proof of unique real-world researcher identity, and publishing organizations are not treated as institutional affiliations.
3 represented evidence records
Years represented: 2012, 2018, 2019
Publishing organizations appearing in records: Analytical chemistry, Drug testing and analysis, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
2 represented evidence records
Years represented: 2012, 2018
Publishing organizations appearing in records: Analytical chemistry, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
2 represented evidence records
Years represented: 1993, 1996
Publishing organizations appearing in records: Clinical endocrinology, The Journal of pediatric endocrinology
2 represented evidence records
Years represented: 2004, 2005
Publishing organizations appearing in records: Arzneimittel-Forschung, Naunyn-Schmiedeberg's archives of pharmacology
2 represented evidence records
Years represented: 2004, 2005
Publishing organizations appearing in records: Arzneimittel-Forschung, Naunyn-Schmiedeberg's archives of pharmacology
2 represented evidence records
Years represented: 2009, 2018
Publishing organizations appearing in records: Endocrine journal, Regulatory peptides
2 represented evidence records
Years represented: 2004, 2007
Publishing organizations appearing in records: Arzneimittel-Forschung, European journal of endocrinology
3 represented evidence records
Years represented: 2004, 2005
Publishing organizations appearing in records: Arzneimittel-Forschung, Naunyn-Schmiedeberg's archives of pharmacology
3 represented evidence records
Years represented: 2004, 2005
Publishing organizations appearing in records: Arzneimittel-Forschung, Naunyn-Schmiedeberg's archives of pharmacology
2 represented evidence records
Years represented: 2012, 2018
Publishing organizations appearing in records: Analytical chemistry, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
2 represented evidence records
Years represented: 2004, 2006
Publishing organizations appearing in records: Arzneimittel-Forschung, Naunyn-Schmiedeberg's archives of pharmacology
2 represented evidence records
Years represented: 2009, 2018
Publishing organizations appearing in records: Endocrine journal, Regulatory peptides
institution
institution
institution
institution
institution
institution
institution
institution
Claim: Not linked · Evidence: 5b007447-8def-539d-8548-323f55fae015
PMID: 17609397 · DOI: 10.1530/EJE-07-0066
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Claim: Not linked · Evidence: 43f428dc-37b3-525f-9246-aedc76794152
PMID: 8949573 · DOI: 10.1046/j.1365-2265.1996.00805.x
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.
Claim: Not linked · Evidence: 1d215325-5fa3-5793-8400-f42ead68f5fb
PMID: 15230633 · DOI: 10.2165/00126839-200405040-00011
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
Claim: Not linked · Evidence: 87cc88c2-2dd0-5309-86b7-55d13b765134
PMID: 15646370 · DOI: 10.1055/s-0031-1297041
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
GH releasing peptides--structure and kinetics.
Claim: Not linked · Evidence: d88ff503-de5d-5a61-9549-40191d07759f
PMID: 8374685 · DOI: 10.1515/jpem.1993.6.1.21
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Glycine-modified growth hormone secretagogues identified in seized doping material.
Claim: Not linked · Evidence: 142528cd-35fa-5b9f-875c-b339bb0a02a2
PMID: 30136411 · DOI: 10.1002/dta.2489
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Analysis of new growth promoting black market products.
Claim: Not linked · Evidence: 6c2397a6-2f0b-5096-907e-573f2ecf0028
PMID: 29864719 · DOI: 10.1016/j.ghir.2018.05.001
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.
Claim: Not linked · Evidence: 84f7aaac-ea48-5b8d-b3a5-fce2e4d43e10
PMID: 29973439 · DOI: 10.1507/endocrj.EJ17-0527
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Detection of black market follistatin 344.
Claim: Not linked · Evidence: 4da1ddc6-3708-5317-bc7b-ff4269edf9d7
PMID: 31758732 · DOI: 10.1002/dta.2741
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.
Claim: Not linked · Evidence: 9d56a3a2-0811-587c-9941-b873317bb984
PMID: 15699539 · DOI: 10.1210/jc.2004-1719
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Growth hormone-releasing peptides.
Claim: Not linked · Evidence: 00b575d7-ed61-5010-b7d7-bf367819c3b1
PMID: 9186261 · DOI: 10.1530/eje.0.1360445
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
The hexapeptide KP-102 (D-ala-D-beta-Nal-ala-trp-D-phe-lys-NH(2)) stimulates growth hormone release in a cichlid fish (Ooreochromis mossambicus).
Claim: Not linked · Evidence: 2e2d0ba3-bf63-5a2e-8cb7-a94436d1fb42
PMID: 11115782 · DOI: 10.1677/joe.0.167r007
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Intraportal infusion of ghrelin could inhibit glucose-stimulated GLP-1 secretion by enteric neural net in Wistar rat.
Claim: Not linked · Evidence: f875a7bf-fc7f-5539-9220-b742e7405a5d
PMID: 25247193 · DOI: 10.1155/2014/923564
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Ipamorelin, the first selective growth hormone secretagogue.
Claim: Not linked · Evidence: 2202e35b-77c4-5254-a290-22fc11ac39bf
PMID: 9849822 · DOI: 10.1530/eje.0.1390552
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.
Claim: Not linked · Evidence: cc02c9e1-3709-5711-bfc2-9a2ec86d84ae
PMID: 35452483 · DOI: 10.1210/jcem.77.3.8103770
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Structure-activity relationship for peptídic growth hormone secretagogues.
Claim: Not linked · Evidence: e75052d8-5b9f-5695-a400-67aa84f9c184
PMID: 26811125 · DOI: 10.1002/dta.1947
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity.
Claim: Not linked · Evidence: 7d4138f8-7981-5225-9e0b-d08b7fd0e440
PMID: 25761386 · DOI: 10.1007/s12272-010-0718-z
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Determination of the immunostimulatory drug-glucosoaminyl-muramyl-dipeptide-in human plasma using HPLC-MS/MS and its application to a pharmacokinetic study.
Claim: Not linked · Evidence: 8f1255be-5d22-5065-a16d-1e75bd34d835
PMID: 32652605 · DOI: 10.1002/bmc.4948
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
Claim: Not linked · Evidence: 455f178a-b291-5ada-bd30-20646a6e3fb7
PMID: 15646371 · DOI: 10.1055/s-0031-1297042
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Metabolism of growth hormone releasing peptides.
Claim: Not linked · Evidence: 7cd2ae37-01f4-5407-a966-8c2b45795467
PMID: 23101768 · DOI: 10.1021/ac302034w
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.
Claim: Not linked · Evidence: 7aa13bc4-4de2-52c2-807a-4475e1208cab
PMID: 28830317 · DOI: 10.1385/endo:22:1:25
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts.
Claim: Not linked · Evidence: ab58134e-0dd5-50db-8d91-0b55c7b076cf
PMID: 16773386 · DOI: 10.1007/s00210-006-0079-9
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary.
Claim: Not linked · Evidence: 4477d488-b21a-59e7-b0b5-4ea133d3b97f
PMID: 19682503 · DOI: 10.1016/j.regpep.2009.07.018
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.
Claim: Not linked · Evidence: 19bdc25a-9c08-500e-9c34-9c1e5a8b5b8e
PMID: 15645295 · DOI: 10.1007/s00210-004-1009-3
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells.
Claim: Not linked · Evidence: 6d89aab6-caec-5790-9e7a-b0ffcae46058
PMID: 27548147 · DOI: 10.1074/jbc.270.42.24965
Extraction: not-recorded · Review: verified · Source state: unknown
Machine extracted: no · Human scientist reviewed: no · Externally validated: no
Incomplete path: claim, extraction-status
Generated: 9/18/2026, 3:17:46 PM
Funding and conflicts are disclosed and considered, but sponsorship never automatically changes a tier. Corrections, retractions, and expressions of concern override the original rating.
This is a representative, sequence-derived model ordered by residue position only. It is not the peptide's experimentally determined or predicted biological conformation, and it carries no claim about real bond angles, distances, secondary structure, binding sites, or activity.
Evidence searched through: Not recorded
Last accountable review: Not recorded
These are documentary and scientific-review signals, not conclusions of harm, ineffectiveness, safety, or absence of research.
This maturity index describes evidence-base development and governance. It is not a probability of efficacy, safety, truth, medical advice, or regulatory approval. Read the methodology.